2005
DOI: 10.1007/s00270-005-0276-9
|View full text |Cite
|
Sign up to set email alerts
|

PTA Versus Carbofilm-Coated Stents in Infrapopliteal Arteries: Pilot Study

Abstract: Infrapopliteal stent application is an effective treatment modality for high-grade lesions in chronic critical limb ischemia. Compared with PTA, higher patency rates can be expected after 6 months.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
82
0
3

Year Published

2006
2006
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 120 publications
(86 citation statements)
references
References 31 publications
1
82
0
3
Order By: Relevance
“…Rand et al [23] compared carbon film coated stents with PTA infrapoplital arteries. At the 50% restenosis threshold, the patency rate of the stents was 79.7% versus 45.6% after PTA in a total of 51 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Rand et al [23] compared carbon film coated stents with PTA infrapoplital arteries. At the 50% restenosis threshold, the patency rate of the stents was 79.7% versus 45.6% after PTA in a total of 51 patients.…”
Section: Discussionmentioning
confidence: 99%
“…The main studies in the literature [13,16,[23][24][25][26][27][28][29][30] reported, for endovascular treatment, a technical success rate of about 90 %, a negligible mortality rate, and a limb salvage rate at 3-5 years of 72-98 %.…”
Section: Discussionmentioning
confidence: 99%
“…In a meta-analysis comparing the results of the surgical and endovascular approach of BTK area, Romiti et al [32] reported a rate of limb salvage at 3 years that was comparable for the two techniques (PTA 82.4 ± 3.4, surgery 82.3 ± 3.0). Several other studies [23][24][25][26][27][28][29][30] evaluated the effectiveness of PTA in diabetic foot patients, but these studies are limited by their main conditions, including a heterogeneous population with BTK and/or ATK disease. Moreover, the effectiveness of BTK-area PTA is still a matter of debate; the small size of the treated vessels appears to be associated with an increased rate of restenosis, and in patients with chronic ATK and BTK knee disease, it is unclear whether the clinical success is linked to the PTA of either the ATK or BTK area alone [33].…”
Section: Discussionmentioning
confidence: 99%
“…Nello studio comparativo condotto da Grimm, con una lunghezza media delle lesioni trattate pari a 2,9 cm±2,5 cm, è riportata infatti una pervietà dell'84,2% ad 1 anno e del 77,2% a 2 anni per la PTA e del 75% ad 1 anno e del 72% a 2 anni per lo stent [13]. Tuttavia in un recente studio eseguito da Rand [14], la pervietà primaria a 6 mesi per lesioni di lunghezza pari a 2,4 cm è risultata significativamente maggiore nel gruppo stent rispetto al gruppo PTA, sia in presenza di restenosi critica (83,7% vs 61,1%) che subcritica (79,7% vs 45,6%) [14]. Sicuramente, l'outcome degli stent appare strettamente influenzato dalla lunghezza del segmento trattato con peggior pervietà a distanza per lesioni lunghe.…”
Section: Discussionunclassified